Zydus receives USFDA approval for Bosentan 32 mg tablets

Mumbai, Feb. 18 -- Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) for Bosentan tablets, oral suspension, 32 mg (USRLD: Tracleer(R) Tablets for Oral Suspension, 32 mg).

Published by HT Digital Content Services with permission from Capital Market....